DERMATITIS
Clinical trials for DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new DERMATITIS trials appear
Sign up with your email to follow new studies for DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested for severe skin rash and itch
Disease control CompletedThis study tested a new drug called camoteskimab for adults with moderate to severe eczema (atopic dermatitis). For the first 16 weeks, some participants received the drug and others received a placebo, then everyone received the drug. The main goal was to see if the drug safely …
Matched conditions: DERMATITIS
Phase: PHASE2 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
AI steps in: can a computer help your doctor spot skin cancer?
Diagnosis CompletedThis study tested whether an artificial intelligence (AI) tool could help doctors more accurately diagnose a wide range of skin conditions, from common rashes to skin cancer. Sixteen doctors first diagnosed 29 skin images on their own, then reviewed the AI's suggestions to see if…
Matched conditions: DERMATITIS
Sponsor: AI Labs Group S.L • Aim: Diagnosis
Last updated Apr 04, 2026 00:05 UTC
-
Spray away ear itch? study tests two treatments
Symptom relief CompletedThis study observed how well two different ear sprays worked for people with chronic itchy, scaly, or irritated skin in their ear canals. Doctors watched 60 patients using either Ectoin Ear Spray or Normison ear spray in their normal lives. The main goal was to see how safe the s…
Matched conditions: DERMATITIS
Sponsor: Bitop AG • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
New eczema drug tested for Kids' itching
Symptom relief CompletedThis study tested if a medication called TAU-284 works as well as an existing drug (ketotifen) to reduce itching in children with atopic dermatitis, also known as eczema. It involved 303 children aged 7 to 15. The main goal was to see if the new treatment was not worse than the s…
Matched conditions: DERMATITIS
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Symptom relief
Last updated Mar 30, 2026 14:29 UTC